Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of S-474474 in patients with essential hypertension
jRCT2080221505Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of irbesartan + trichlormethiazide in essential hypertension, sponsored by Shionogi & Co., Ltd.
02
Drugs
irbesartan + trichlormethiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCT2080221505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221505.